From the clinic to the lab, understanding medulloblastoma relies on molecular profiling
- OPACC
- Feb 1, 2021
- 1 min read
A pair of research papers from St. Jude Children's Research Hospital report on a medulloblastoma clinical trial that provides insights to guide treatment and shed light on relapsed disease.
Comments